Stocks and InvestingStocks and Investing
Thu, August 4, 2022
Wed, August 3, 2022
Tue, August 2, 2022

Dane Leone Upgraded (BLUE) to Buy and Held Target at $8 on, Aug 2nd, 2022


Published on 2024-10-27 22:22:49 - WOPRAI, Dane Leone
  Print publication without navigation


Dane Leone of Raymond James, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Held Target at $8 on, Aug 2nd, 2022.

Dane has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Dane's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022


These are the ratings of the 3 analyists that currently disagree with Dane


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $2 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022
  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 10th, 2022